SMN2 and proximal spinal muscular atrophy: This revealed a lack of binding between SMN and WRAP53 in cells from SMA patients that cannot be explained by the lower amounts of SMN, and that the relative binding between WRAP53 and SMN in these cells was reduced by 83% (Figure 7D).